These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 24521853)
1. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study. Hwang TJ; Hooper DC J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853 [No Abstract] [Full Text] [Related]
2. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240 [TBL] [Abstract][Full Text] [Related]
3. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients. Tayfour M; Yuce A; Yulug N Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939 [TBL] [Abstract][Full Text] [Related]
4. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Caron F; Etienne M Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811 [No Abstract] [Full Text] [Related]
5. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology. Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678 [TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of Escherichia coli isolated from urine in Thailand from 2000 to 2005. Polwichai P; Dejsirilert S; Panpetch S; Sawanpanyalert P; Aswapokee N; Mootsikapun P J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S59-67. PubMed ID: 21298846 [TBL] [Abstract][Full Text] [Related]
7. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications. In vitro resistance of E coli to TMP/SMX. Postgrad Med; 2001 Aug; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571 [No Abstract] [Full Text] [Related]
9. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli. Gagliotti C; Buttazzi R; Sforza S; Moro ML; J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763 [TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study. Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598 [TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country. Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371 [TBL] [Abstract][Full Text] [Related]
12. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin. Karlowsky JA; Thornsberry C; Jones ME; Sahm DF Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750 [TBL] [Abstract][Full Text] [Related]